OUR 9TH YEAR OF PROVIDING PROPRIETARY CAPITAL MARKETS INTELLIGENCE ON THE CANNABIS / HEMP / PSYCHEDELIC SECTORS
Equity Capital Raises
Equity Transaction Chart
Viridian publishes weekly data on equity capital raises in the Cannabis/CBD/Psychedelic industries. This data includes information about the company issuing equity (public/private, state/country location), deal size, deal structure, pricing, share information, deal implied valuation, and warrant information.
Week ended 01/05/2024
Week ended 01/05/2024
This Section is Only Available to Higher Tier Memberships
Please Purchase a Premium or Enterprise membership to see more.
Equity Commentary
Week ended 01/05/2024
- The Week’s Closed Equity Deals
- Beckley Psytec Limited (Private), a company whose products include BPL-003, an intranasal DMT, ELE-101 intravenous psilocin, and BPL-003, a short-duration psychedelic for treatment of depression, received a $50M investment from Atai Life Sciences.
- $40M of the investment was primary issuance, and $10M was secondary sales from existing shareholders.
- Atai will also receive 1:1 warrant coverage at a 30% premium on primary issuance.
- Atai will get 3 of the nine seats on the board and rights of refusal for the sale of the company or any of its key products.
Public vs. Private Raises:
- One of this week’s issuers was public, trading in Canada on the CSE and the U.S. on OTCQB.
Equity vs. Debt Cap Raises:
- Equity accounts for 99.5% of this week’s capital raises.
Week ended 01/05/2024
Additional content is available to Premium and Enterprise users. Please purchase a higher tier membership to see more.
Weekly Valuation Tracker
Viridian highlights a specific industry sector and provides a deep dive into valuation metrics and comparable company valuations for public companies operating in that sector. The Weekly Valuation Tracker provides proprietary, actionable valuation data.
- Week ended 01/05/2024
This week’s valuation tracker focuses on the 7 U.S. MSOs with market cap over $500M in the Viridian Value Tracker database in gauge the valuation impact of the 2nd earnings that have been released so far, Green Thumb (GTII: CSE), Curaleaf (CURA: CSE), and Trulieve.
- Week ended 01/05/2024
This Chart is Only Available to Higher Tier Memberships
Please Purchase a Premium or Enterprise membership to see more.
Additional content is available to Premium and Enterprise users. Please purchase a higher tier membership to see more.
This Chart is Only Available to Higher Tier Memberships
Please Purchase a Premium or Enterprise membership to see more.
Viridian publishes weekly insights on equity capital raises in the Cannabis/CBD/Psychedelic industries. These insights typically highlight the most interesting/meaningful equity transactions of that week, and commentary on market conditions, equity deal structures and investor groups.